Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Last 12 months price action with 12-month analyst target path
As of May 6, 2026, Invesco Ltd. (IVZ) has a Wall Street consensus price target of $29.72, based on estimates from 28 covering analysts. With the stock currently trading at $26.83, this represents a potential upside of +10.8%. The company has a market capitalization of $11.92B.
Analyst price targets range from a low of $26.00 to a high of $34.50, representing a 29% spread in expectations. The median target of $30.00 aligns closely with the consensus average.
The current analyst consensus rating is Hold, with 12 analysts rating the stock as a Buy or Strong Buy,16 rating it Hold, and 0 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, IVZ trades at a trailing P/E of -16.8x and forward P/E of 10.4x. Analysts expect EPS to grow +579.2% over the next year.
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs Berkshire Hathaway Inc..
Start ComparisonQuick answers to the most common questions about buying IVZ stock.
Invesco Ltd. (IVZ) has a consensus 12-month price target of $29.72, implying 10.8% upside from $26.83. The 28 analysts covering IVZ see moderate appreciation potential.
IVZ has a consensus rating of "Hold" based on 28 Wall Street analysts. The rating breakdown is mixed, with 16 Hold ratings making up the largest segment. The consensus 12-month price target of $29.72 implies 10.8% upside from current levels.
With a forward P/E of 10.436x, IVZ trades at a relatively low valuation. The consensus target of $29.72 implies 10.8% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $34.5 for IVZ, while the most conservative target is $26. The consensus of $29.72 represents the median expectation. These targets typically reflect 12-month expectations.
IVZ is heavily covered by Wall Street, with 28 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 12 have Buy ratings, 16 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month IVZ stock forecast based on 28 Wall Street analysts shows a consensus price target of $29.72, with estimates ranging from $26 (bear case) to $34.5 (bull case). The median consensus rating is "Hold".
IVZ trades at a forward P/E ratio of 10.4x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are optimistic on IVZ, with a "Hold" consensus rating and $29.72 price target (10.8% upside). 12 of 28 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
IVZ analyst price targets range from $26 to $34.5, a 29% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $29.72 consensus represents the middle ground.